What is the current stock price of Mural Oncology plc (MURA)?

As of the latest market data, Mural Oncology plc (MURA) is trading at $2.04. The stock has seen a loss of 0.00% today.

Does Mural Oncology plc (MURA) pay a dividend?

Based on current data, Mural Oncology plc does not have a confirmed active dividend policy.

What is the market cap of Mural Oncology plc?

The current market capitalization of Mural Oncology plc (MURA) is approximately unavailable.

MURA

Mural Oncology plc·Healthcare

2.04

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.9552W H: $4.74

MURA NEWS

defenseworld.net

Jan 14

Mural Oncology PLC (NASDAQ:MURA) Receives $12.00 Consensus PT from Brokerages

Mural Oncology PLC (NASDAQ: MURA - Get Free Report) has been given an average recommendation of "Hold" by the five research firms that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating on the

Company Profile

Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. The company was incorporated in 2017 and is based in Dublin, Ireland. As of November 15, 2023, Mural Oncology Plc operates as a former subsidiary of Alkermes plc.

Sector

Healthcare

Industry

Biotechnology

Employees

116

IPO Date

2023-11-16

Beta

2.96

Websitewww.muraloncology.com↗